FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, precision agriculture, and professional pest, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

FMC achieves record Q4 results, eyes growth amid cost challenges

FMC's strong Q4 performance and full-year results reflect growth across regions and product segments. While facing short-term challenges like cost pressures and supply disruptions, the company is poised for revenue and EBITDA growth in 2023. Strategic initiatives in sustainability, innovation, and market expansion position FMC for long-term success.

FMC reports solid Q1 earnings, focuses on growth and sustainability

FMC's Q1 performance was solid, driven by revenue growth and adjusted EBITDA increase, despite regional challenges.
The company's focus on new products, market access, and sustainability aligns with future growth strategies.
Challenges in Latin America and Asia require strategic management, while opportunities lie in cash flow growth and market expansion.
Overall, FMC's outlook remains positive with a commitment to innovation, sustainability, and financial resilience.

FMC reports Q2 sales decline, anticipates rebound in 2024

FMC faced challenges in Q2 with sales decline due to volume drop, impacting EBITDA and free cash flow guidance for 2023.
Despite challenges, the company is adapting by controlling costs, investing in R&D, and focusing on new product sales for long-term growth.
Opportunities lie in stabilizing inventory levels, focusing on R&D pipeline, and anticipating a rebound in cash flow as market conditions normalize.
FMC remains confident in managing through demand shocks, with a focus on customer intimacy, commercial operations, and market access for growth.

FMC reports Q3 revenue decline, eyes growth in 2024

FMC's Q3 performance saw revenue and EBITDA decline significantly, impacting free cash flow. Despite challenges in working capital and inventory levels, the company is focusing on growth strategies for its products. Opportunities lie in potential price increases, new product introductions, and positive sales growth projections for 2024.

FMC projects revenue growth in 2024 despite regional challenges

FMC faces challenges in certain regions but maintains a strong margin and optimistic revenue guidance for 2024, driven by new products.
The company's focus on operational efficiency through global restructuring and inventory management positions it for future growth.
Despite short-term adjustments, FMC's long-term targets remain intact, with expectations of accelerated growth in 2025.
Strong commercial performance with new products and strategic resilience in core businesses highlight FMC's potential for sustained growth.

FMC Corporation reports robust Q3 earnings, anticipates strong Q4 growth

FMC's Q3 performance showcased resilience and growth despite regional challenges. The company's focus on new product development and cost savings initiatives bodes well for future profitability. With strong Q4 projections, FMC is poised for continued success in the coming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

Our proven model does not show that FMC Corp (FMC) is likely to beat estimates in Q1.

FMC Corp (FMC) to Post Q1 Earnings: What's in the Cards?

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: FMC (FMC) Q1 Earnings Expected to Decline

The agricultural sciences leader reported full-year 2018 operating results, then abruptly sank in early March.

Here's Why FMC Corporation Rose 12.2% in February, Then Collapsed in Early March

News for FMC Stock (FMC)